CN Stock MarketDetailed Quotes

600201 Jinyu Bio-Technology

Watchlist

7.49
+0.15+2.04%

Noon Break Jun 21 11:29 CST

8.39BMarket Cap29.72P/E (TTM)

Jinyu Bio-Technology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

20.05%1.67B

21.83%1.71B

50.86%1.8B

62.33%1.92B

1.88%1.39B

5.34%1.41B

-26.03%1.19B

-17.67%1.18B

-6.08%1.37B

-12.00%1.33B

Transactional financial assets

2.65%45.63M

-20.59%37.27M

-55.62%52.02M

-68.52%44.45M

-69.29%44.45M

-74.47%46.94M

-49.98%117.2M

-51.12%141.21M

-75.54%144.75M

-71.25%183.85M

Notes receivable and accounts receivable

-15.68%773.28M

6.51%869.84M

9.08%947.26M

-0.64%819.51M

6.06%917.04M

9.93%816.65M

-0.71%868.37M

6.75%824.81M

5.03%864.6M

18.36%742.88M

-Notes receivable

-75.00%17.81M

-76.87%12.34M

-68.60%24.3M

-59.90%33.64M

96.08%71.23M

287.33%53.38M

26.31%77.4M

345.24%83.9M

311.28%36.33M

-37.46%13.78M

-Accounts receivable

-10.68%755.47M

12.35%857.49M

16.69%922.95M

6.07%785.87M

2.12%845.8M

4.69%763.26M

-2.75%790.96M

-1.71%740.91M

1.71%828.27M

20.39%729.09M

Other receivables (including interest and dividends)

-46.62%39.52M

-30.89%33.66M

-26.48%40.1M

-23.47%51.73M

1.94%74.04M

28.73%48.7M

-4.59%54.55M

18.11%67.6M

28.23%72.63M

5.09%37.83M

-Other receivable

----

-23.47%51.73M

----

28.73%48.7M

----

18.11%67.6M

----

5.09%37.83M

Advance payment

16.69%24.75M

64.99%16.75M

43.67%29.05M

-0.94%17.42M

95.90%21.21M

4.34%10.15M

-35.23%20.22M

-44.20%17.59M

2.84%10.83M

48.74%9.73M

Inventories

-12.93%301.04M

-3.36%322.25M

-0.52%300.04M

-1.94%328.57M

4.16%345.74M

4.98%333.46M

-5.87%301.61M

-11.55%335.06M

-7.70%331.92M

-9.41%317.65M

Other current assets

12.47%24.16M

23.69%23.92M

-84.57%21.17M

-84.49%21M

-84.08%21.48M

-85.62%19.34M

1,144.35%137.17M

620.94%135.44M

1,166.63%134.9M

1,163.36%134.54M

Total current assets

2.27%2.88B

12.51%3.02B

18.49%3.19B

18.44%3.2B

-3.76%2.82B

-2.90%2.68B

-14.31%2.69B

-9.39%2.71B

-11.52%2.93B

-13.38%2.76B

Non Current assets

Other equity investment

522.27%278.7M

208.98%137.9M

28.43%44.73M

28.65%44.81M

28.43%44.79M

28.44%44.63M

-0.62%34.83M

-0.43%34.83M

0.25%34.87M

-0.03%34.75M

Investment real estate

-3.49%99.32M

-3.46%100.22M

-3.43%101.12M

-3.40%102.02M

-3.37%102.91M

-3.35%103.81M

-3.32%104.71M

-3.29%105.61M

-3.26%106.51M

-3.24%107.41M

Long-term equity investment

-0.05%266.23M

-0.22%266.28M

-0.27%266.36M

-0.51%266.28M

-0.59%266.37M

-0.54%266.85M

1.31%267.09M

0.61%267.64M

0.60%267.95M

0.59%268.3M

Fixed assets

----

-6.05%1.58B

----

-2.55%1.64B

----

1.95%1.68B

----

-0.84%1.68B

Constru in process

----

64.43%200.69M

----

17.85%151.72M

----

86.29%122.05M

----

514.99%128.74M

Intangible assets

1.21%341.21M

1.38%352.12M

-8.78%328.11M

-10.60%326.46M

-10.78%337.14M

-10.59%347.32M

-8.84%359.69M

2.45%365.15M

11.42%377.88M

13.09%388.45M

Development expenditure

16.08%386.74M

17.29%376.71M

8.81%331.76M

21.09%341.75M

22.97%333.18M

23.51%321.19M

29.81%304.89M

13.39%282.23M

9.35%270.95M

11.51%260.06M

Goodwill

-61.31%11.41M

-68.80%29.49M

-29.61%94.5M

Long deferred expense

27.74%1.63M

5.58%1.41M

-17.02%1.16M

-17.86%1.21M

237.67%1.28M

1,224.43%1.34M

-73.02%1.39M

-71.82%1.48M

-92.94%377.8K

-75.49%100.8K

Deferred tax assets

14.84%96.29M

16.25%96.99M

-5.51%84.78M

-0.10%88.29M

-4.78%83.85M

-3.16%83.43M

3.78%89.73M

6.69%88.38M

3.40%88.06M

5.39%86.15M

Usufruct assets

62.13%8.84M

58.99%9.11M

-1.62%5.1M

-2.15%5.25M

-1.56%5.45M

0.25%5.73M

--5.19M

--5.36M

--5.54M

12.45%5.72M

Other non current assets

2.12%672.21M

-12.69%621.22M

-10.69%626.9M

-46.00%398.75M

-11.09%658.22M

-9.31%711.51M

79.36%701.97M

79.18%738.37M

198.21%740.31M

388.01%784.56M

Total non current assets

11.01%4.04B

3.99%3.86B

-3.86%3.61B

-10.63%3.38B

-3.95%3.64B

-3.50%3.71B

10.00%3.75B

12.56%3.78B

19.61%3.79B

24.33%3.84B

Total assets

7.19%6.92B

7.56%6.87B

5.48%6.8B

1.49%6.59B

-3.87%6.46B

-3.25%6.39B

-1.66%6.45B

2.24%6.49B

3.70%6.72B

5.19%6.6B

Liabilities

Current liabilities

Short term loan

----

--10.01M

--60M

--10M

----

Notes payable and accounts payable

-17.70%307.1M

-8.46%324.41M

-3.02%342.65M

4.06%337.53M

-4.35%373.15M

2.12%354.41M

17.42%353.32M

22.37%324.38M

24.81%390.11M

5.07%347.05M

-Notes payable

12.50%20.62M

41.31%18.26M

11.03%35.9M

230.91%38.54M

477.96%18.33M

146.38%12.92M

728.06%32.33M

--11.65M

--3.17M

--5.24M

-Accounts payable

-19.26%286.49M

-10.35%306.15M

-4.44%306.75M

-4.39%299M

-8.30%354.82M

-0.09%341.49M

8.08%320.99M

17.98%312.73M

23.80%386.94M

3.48%341.81M

Contract liabilities

13.96%96.08M

15.42%97.7M

18.31%101.82M

3.05%105.2M

2.76%84.31M

2.54%84.65M

0.24%86.07M

8.07%102.08M

1.87%82.05M

2.72%82.55M

Advance receipts

----

--683.07K

----

Salaries payable

-14.00%30.73M

5.93%66.1M

-4.73%38.72M

7.36%36.79M

-0.78%35.73M

-8.53%62.4M

-10.57%40.65M

-8.27%34.27M

-2.64%36.02M

-4.16%68.22M

Taxs payable

43.34%26.65M

-36.92%18.06M

8.03%34.69M

-32.08%13.2M

-11.94%18.6M

42.10%28.64M

-17.22%32.11M

40.69%19.44M

-53.39%21.12M

-7.05%20.15M

Other payable (including interest and dividends)

382.05%259.45M

311.30%269.07M

298.45%240.06M

35.79%236.07M

-58.24%53.82M

-51.06%65.42M

-65.12%60.25M

1.90%173.85M

-20.95%128.88M

-19.83%133.66M

-Interest payable

0.00%241.96K

-Dividend payable

0.00%1.2M

-99.02%1.2M

-38.47%1.2M

814.52%122.26M

62.51%1.95M

-Other payable

392.55%258.01M

318.30%267.63M

305.76%238.62M

356.96%234.63M

-58.65%52.38M

-51.34%63.98M

-65.52%58.81M

-67.30%51.35M

-21.60%126.7M

-20.46%131.47M

Non current liabilities due within one year

392.73%1.6M

186.58%1.53M

-51.76%152.41K

-44.81%260.05K

-47.33%325.19K

-13.44%534.45K

--315.95K

--471.19K

--617.44K

Other current liabilities

1.21%52.68M

19.38%62.89M

1.50%53.17M

-0.62%52.73M

-0.99%52.05M

42.78%52.68M

2,061.65%52.38M

1,790.40%53.06M

1,916.42%52.57M

298.13%36.9M

Total current liabilities

25.30%774.31M

27.58%840.45M

18.42%811.27M

1.85%781.79M

-14.33%617.99M

-4.41%658.75M

6.02%685.09M

31.40%767.55M

12.53%721.36M

1.42%689.15M

Current liabilities

Deferred tax liabilities

-8.21%9.37M

-5.21%9.63M

-5.52%9.63M

-4.53%9.8M

-1.19%10.21M

-3.13%10.15M

-1.80%10.2M

-1.17%10.26M

-0.53%10.33M

0.94%10.48M

Long term deferred income

-2.54%358.23M

-1.53%364.84M

3.22%362.41M

4.11%363.93M

8.17%367.55M

7.73%370.49M

9.35%351.09M

1.50%349.58M

0.82%339.8M

5.68%343.9M

Lease liabilities

798.19%2.79M

789.94%2.73M

--208.28K

--204.78K

86.64%311.15K

93.41%307.31K

----

--166.71K

--158.89K

Total non current liabilities

-2.03%370.39M

-0.99%377.2M

3.03%372.26M

3.92%373.93M

7.93%378.07M

7.45%380.95M

9.00%361.29M

1.43%359.84M

0.83%350.3M

5.58%354.54M

Total liabilities

14.92%1.14B

17.12%1.22B

13.11%1.18B

2.51%1.16B

-7.05%996.05M

-0.38%1.04B

7.03%1.05B

20.07%1.13B

8.42%1.07B

2.79%1.04B

Shareholders equity

Paid-in capital

0.00%1.12B

-0.52%1.12B

-0.00%1.13B

Capital reserve funds

8.20%902.75M

6.86%891.52M

3.66%864.86M

-4.90%849.58M

-6.61%834.3M

-8.25%834.3M

-0.99%893.34M

-0.12%893.34M

0.75%893.34M

Surplus reserve funds

3.89%514.52M

6.98%495.23M

6.89%462.92M

Retained profit

6.39%3.26B

6.66%3.16B

6.33%3.18B

4.87%3.03B

2.80%3.07B

1.99%2.96B

0.79%2.99B

2.81%2.89B

3.01%2.98B

8.10%2.9B

Less:Treasury stock

0.00%338.48M

15.60%338.48M

15.28%338.48M

198.63%338.48M

96.14%292.81M

95.71%293.61M

-24.45%113.34M

Other composite income

13,925.65%23.76M

5,089.14%20.46M

-785.05%-244.82K

-480.85%-244.46K

-51.98%-171.83K

-76.22%-410.06K

-134.14%-27.66K

-474.01%-42.09K

30.42%-113.06K

-18.29%-232.69K

Shareholders equity without minority interests

5.94%5.49B

5.81%5.37B

4.04%5.32B

1.54%5.16B

-3.25%5.18B

-3.79%5.07B

-3.24%5.12B

-0.85%5.08B

2.93%5.35B

5.83%5.27B

Minority interests

2.82%289M

3.82%288.06M

3.36%292.05M

-3.52%275.34M

-3.42%281.08M

-3.66%277.45M

-2.13%282.57M

-0.97%285.39M

1.35%291.02M

2.38%287.98M

Total shareholder equity

5.78%5.78B

5.71%5.65B

4.00%5.62B

1.27%5.43B

-3.26%5.46B

-3.79%5.35B

-3.18%5.4B

-0.86%5.36B

2.85%5.64B

5.65%5.56B

Total liabilityies and equity

7.19%6.92B

7.56%6.87B

5.48%6.8B

1.49%6.59B

-3.87%6.46B

-3.25%6.39B

-1.66%6.45B

2.24%6.49B

3.70%6.72B

5.19%6.6B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Grant Tung Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	20.05%1.67B	21.83%1.71B	50.86%1.8B	62.33%1.92B	1.88%1.39B	5.34%1.41B	-26.03%1.19B	-17.67%1.18B	-6.08%1.37B	-12.00%1.33B
Transactional financial assets	2.65%45.63M	-20.59%37.27M	-55.62%52.02M	-68.52%44.45M	-69.29%44.45M	-74.47%46.94M	-49.98%117.2M	-51.12%141.21M	-75.54%144.75M	-71.25%183.85M
Notes receivable and accounts receivable	-15.68%773.28M	6.51%869.84M	9.08%947.26M	-0.64%819.51M	6.06%917.04M	9.93%816.65M	-0.71%868.37M	6.75%824.81M	5.03%864.6M	18.36%742.88M
-Notes receivable	-75.00%17.81M	-76.87%12.34M	-68.60%24.3M	-59.90%33.64M	96.08%71.23M	287.33%53.38M	26.31%77.4M	345.24%83.9M	311.28%36.33M	-37.46%13.78M
-Accounts receivable	-10.68%755.47M	12.35%857.49M	16.69%922.95M	6.07%785.87M	2.12%845.8M	4.69%763.26M	-2.75%790.96M	-1.71%740.91M	1.71%828.27M	20.39%729.09M
Other receivables (including interest and dividends)	-46.62%39.52M	-30.89%33.66M	-26.48%40.1M	-23.47%51.73M	1.94%74.04M	28.73%48.7M	-4.59%54.55M	18.11%67.6M	28.23%72.63M	5.09%37.83M
-Other receivable	----	----	----	-23.47%51.73M	----	28.73%48.7M	----	18.11%67.6M	----	5.09%37.83M
Advance payment	16.69%24.75M	64.99%16.75M	43.67%29.05M	-0.94%17.42M	95.90%21.21M	4.34%10.15M	-35.23%20.22M	-44.20%17.59M	2.84%10.83M	48.74%9.73M
Inventories	-12.93%301.04M	-3.36%322.25M	-0.52%300.04M	-1.94%328.57M	4.16%345.74M	4.98%333.46M	-5.87%301.61M	-11.55%335.06M	-7.70%331.92M	-9.41%317.65M
Other current assets	12.47%24.16M	23.69%23.92M	-84.57%21.17M	-84.49%21M	-84.08%21.48M	-85.62%19.34M	1,144.35%137.17M	620.94%135.44M	1,166.63%134.9M	1,163.36%134.54M
Total current assets	2.27%2.88B	12.51%3.02B	18.49%3.19B	18.44%3.2B	-3.76%2.82B	-2.90%2.68B	-14.31%2.69B	-9.39%2.71B	-11.52%2.93B	-13.38%2.76B
Non Current assets
Other equity investment	522.27%278.7M	208.98%137.9M	28.43%44.73M	28.65%44.81M	28.43%44.79M	28.44%44.63M	-0.62%34.83M	-0.43%34.83M	0.25%34.87M	-0.03%34.75M
Investment real estate	-3.49%99.32M	-3.46%100.22M	-3.43%101.12M	-3.40%102.02M	-3.37%102.91M	-3.35%103.81M	-3.32%104.71M	-3.29%105.61M	-3.26%106.51M	-3.24%107.41M
Long-term equity investment	-0.05%266.23M	-0.22%266.28M	-0.27%266.36M	-0.51%266.28M	-0.59%266.37M	-0.54%266.85M	1.31%267.09M	0.61%267.64M	0.60%267.95M	0.59%268.3M
Fixed assets	----	----	----	-6.05%1.58B	----	-2.55%1.64B	----	1.95%1.68B	----	-0.84%1.68B
Constru in process	----	----	----	64.43%200.69M	----	17.85%151.72M	----	86.29%122.05M	----	514.99%128.74M
Intangible assets	1.21%341.21M	1.38%352.12M	-8.78%328.11M	-10.60%326.46M	-10.78%337.14M	-10.59%347.32M	-8.84%359.69M	2.45%365.15M	11.42%377.88M	13.09%388.45M
Development expenditure	16.08%386.74M	17.29%376.71M	8.81%331.76M	21.09%341.75M	22.97%333.18M	23.51%321.19M	29.81%304.89M	13.39%282.23M	9.35%270.95M	11.51%260.06M
Goodwill	-61.31%11.41M	-61.31%11.41M	-68.80%29.49M	-68.80%29.49M	-68.80%29.49M	-68.80%29.49M	-29.61%94.5M	-29.61%94.5M	-29.61%94.5M	-29.61%94.5M
Long deferred expense	27.74%1.63M	5.58%1.41M	-17.02%1.16M	-17.86%1.21M	237.67%1.28M	1,224.43%1.34M	-73.02%1.39M	-71.82%1.48M	-92.94%377.8K	-75.49%100.8K
Deferred tax assets	14.84%96.29M	16.25%96.99M	-5.51%84.78M	-0.10%88.29M	-4.78%83.85M	-3.16%83.43M	3.78%89.73M	6.69%88.38M	3.40%88.06M	5.39%86.15M
Usufruct assets	62.13%8.84M	58.99%9.11M	-1.62%5.1M	-2.15%5.25M	-1.56%5.45M	0.25%5.73M	--5.19M	--5.36M	--5.54M	12.45%5.72M
Other non current assets	2.12%672.21M	-12.69%621.22M	-10.69%626.9M	-46.00%398.75M	-11.09%658.22M	-9.31%711.51M	79.36%701.97M	79.18%738.37M	198.21%740.31M	388.01%784.56M
Total non current assets	11.01%4.04B	3.99%3.86B	-3.86%3.61B	-10.63%3.38B	-3.95%3.64B	-3.50%3.71B	10.00%3.75B	12.56%3.78B	19.61%3.79B	24.33%3.84B
Total assets	7.19%6.92B	7.56%6.87B	5.48%6.8B	1.49%6.59B	-3.87%6.46B	-3.25%6.39B	-1.66%6.45B	2.24%6.49B	3.70%6.72B	5.19%6.6B
Liabilities
Current liabilities
Short term loan	----	----	----	----	----	--10.01M	--60M	--60M	--10M	----
Notes payable and accounts payable	-17.70%307.1M	-8.46%324.41M	-3.02%342.65M	4.06%337.53M	-4.35%373.15M	2.12%354.41M	17.42%353.32M	22.37%324.38M	24.81%390.11M	5.07%347.05M
-Notes payable	12.50%20.62M	41.31%18.26M	11.03%35.9M	230.91%38.54M	477.96%18.33M	146.38%12.92M	728.06%32.33M	--11.65M	--3.17M	--5.24M
-Accounts payable	-19.26%286.49M	-10.35%306.15M	-4.44%306.75M	-4.39%299M	-8.30%354.82M	-0.09%341.49M	8.08%320.99M	17.98%312.73M	23.80%386.94M	3.48%341.81M
Contract liabilities	13.96%96.08M	15.42%97.7M	18.31%101.82M	3.05%105.2M	2.76%84.31M	2.54%84.65M	0.24%86.07M	8.07%102.08M	1.87%82.05M	2.72%82.55M
Advance receipts	----	--683.07K	----	----	----	----	----	----	----	----
Salaries payable	-14.00%30.73M	5.93%66.1M	-4.73%38.72M	7.36%36.79M	-0.78%35.73M	-8.53%62.4M	-10.57%40.65M	-8.27%34.27M	-2.64%36.02M	-4.16%68.22M
Taxs payable	43.34%26.65M	-36.92%18.06M	8.03%34.69M	-32.08%13.2M	-11.94%18.6M	42.10%28.64M	-17.22%32.11M	40.69%19.44M	-53.39%21.12M	-7.05%20.15M
Other payable (including interest and dividends)	382.05%259.45M	311.30%269.07M	298.45%240.06M	35.79%236.07M	-58.24%53.82M	-51.06%65.42M	-65.12%60.25M	1.90%173.85M	-20.95%128.88M	-19.83%133.66M
-Interest payable	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K
-Dividend payable	0.00%1.2M	0.00%1.2M	0.00%1.2M	-99.02%1.2M	-38.47%1.2M	-38.47%1.2M	-38.47%1.2M	814.52%122.26M	62.51%1.95M	62.51%1.95M
-Other payable	392.55%258.01M	318.30%267.63M	305.76%238.62M	356.96%234.63M	-58.65%52.38M	-51.34%63.98M	-65.52%58.81M	-67.30%51.35M	-21.60%126.7M	-20.46%131.47M
Non current liabilities due within one year	392.73%1.6M	186.58%1.53M	-51.76%152.41K	-44.81%260.05K	-47.33%325.19K	-13.44%534.45K	--315.95K	--471.19K	--617.44K	--617.44K
Other current liabilities	1.21%52.68M	19.38%62.89M	1.50%53.17M	-0.62%52.73M	-0.99%52.05M	42.78%52.68M	2,061.65%52.38M	1,790.40%53.06M	1,916.42%52.57M	298.13%36.9M
Total current liabilities	25.30%774.31M	27.58%840.45M	18.42%811.27M	1.85%781.79M	-14.33%617.99M	-4.41%658.75M	6.02%685.09M	31.40%767.55M	12.53%721.36M	1.42%689.15M
Current liabilities
Deferred tax liabilities	-8.21%9.37M	-5.21%9.63M	-5.52%9.63M	-4.53%9.8M	-1.19%10.21M	-3.13%10.15M	-1.80%10.2M	-1.17%10.26M	-0.53%10.33M	0.94%10.48M
Long term deferred income	-2.54%358.23M	-1.53%364.84M	3.22%362.41M	4.11%363.93M	8.17%367.55M	7.73%370.49M	9.35%351.09M	1.50%349.58M	0.82%339.8M	5.68%343.9M
Lease liabilities	798.19%2.79M	789.94%2.73M	--208.28K	--204.78K	86.64%311.15K	93.41%307.31K	----	----	--166.71K	--158.89K
Total non current liabilities	-2.03%370.39M	-0.99%377.2M	3.03%372.26M	3.92%373.93M	7.93%378.07M	7.45%380.95M	9.00%361.29M	1.43%359.84M	0.83%350.3M	5.58%354.54M
Total liabilities	14.92%1.14B	17.12%1.22B	13.11%1.18B	2.51%1.16B	-7.05%996.05M	-0.38%1.04B	7.03%1.05B	20.07%1.13B	8.42%1.07B	2.79%1.04B
Shareholders equity
Paid-in capital	0.00%1.12B	0.00%1.12B	0.00%1.12B	-0.52%1.12B	-0.52%1.12B	-0.52%1.12B	-0.52%1.12B	-0.00%1.13B	-0.00%1.13B	-0.00%1.13B
Capital reserve funds	8.20%902.75M	6.86%891.52M	3.66%864.86M	-4.90%849.58M	-6.61%834.3M	-6.61%834.3M	-8.25%834.3M	-0.99%893.34M	-0.12%893.34M	0.75%893.34M
Surplus reserve funds	3.89%514.52M	3.89%514.52M	6.98%495.23M	6.98%495.23M	6.98%495.23M	6.98%495.23M	6.89%462.92M	6.89%462.92M	6.89%462.92M	6.89%462.92M
Retained profit	6.39%3.26B	6.66%3.16B	6.33%3.18B	4.87%3.03B	2.80%3.07B	1.99%2.96B	0.79%2.99B	2.81%2.89B	3.01%2.98B	8.10%2.9B
Less:Treasury stock	0.00%338.48M	0.00%338.48M	15.60%338.48M	15.28%338.48M	198.63%338.48M	198.63%338.48M	96.14%292.81M	95.71%293.61M	-24.45%113.34M	-24.45%113.34M
Other composite income	13,925.65%23.76M	5,089.14%20.46M	-785.05%-244.82K	-480.85%-244.46K	-51.98%-171.83K	-76.22%-410.06K	-134.14%-27.66K	-474.01%-42.09K	30.42%-113.06K	-18.29%-232.69K
Shareholders equity without minority interests	5.94%5.49B	5.81%5.37B	4.04%5.32B	1.54%5.16B	-3.25%5.18B	-3.79%5.07B	-3.24%5.12B	-0.85%5.08B	2.93%5.35B	5.83%5.27B
Minority interests	2.82%289M	3.82%288.06M	3.36%292.05M	-3.52%275.34M	-3.42%281.08M	-3.66%277.45M	-2.13%282.57M	-0.97%285.39M	1.35%291.02M	2.38%287.98M
Total shareholder equity	5.78%5.78B	5.71%5.65B	4.00%5.62B	1.27%5.43B	-3.26%5.46B	-3.79%5.35B	-3.18%5.4B	-0.86%5.36B	2.85%5.64B	5.65%5.56B
Total liabilityies and equity	7.19%6.92B	7.56%6.87B	5.48%6.8B	1.49%6.59B	-3.87%6.46B	-3.25%6.39B	-1.66%6.45B	2.24%6.49B	3.70%6.72B	5.19%6.6B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Grant Tung Certified Public Accountants (Special General Partnership)	--	--	--	Grant Tung Certified Public Accountants (Special General Partnership)	--	--	--	Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

600201 Jinyu Bio-Technology

Jinyu Bio-Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target